Eupraxia Pharmaceuticals Reveals Compelling Financial Results for Q4 2024 Eupraxia Pharmaceuticals Inc. announces its Q4 2024 financial results highlighting significant advancements in clinical trials and improved financial health.

Eupraxia Pharmaceuticals Reveals Compelling Financial Results for Q4 2024 #Canada #Victoria #EP-104GI #Eupraxia #DiffuSphere